Wenyi Jiang

449 total citations
13 papers, 355 citations indexed

About

Wenyi Jiang is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Wenyi Jiang has authored 13 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Wenyi Jiang's work include Liver physiology and pathology (2 papers), Epigenetics and DNA Methylation (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Wenyi Jiang is often cited by papers focused on Liver physiology and pathology (2 papers), Epigenetics and DNA Methylation (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Wenyi Jiang collaborates with scholars based in China, South Korea and Japan. Wenyi Jiang's co-authors include Yi Zhang, Sung Hee Lee, Dong Hwan Sohn, Geom Seog Seo, Liping Wang, Bin Zhang, Youn‐Chul Kim, Jingyao Lian, Ying Yue and Dan Wang and has published in prestigious journals such as International Journal of Cancer, Molecules and European Journal of Immunology.

In The Last Decade

Wenyi Jiang

12 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyi Jiang China 10 145 140 104 60 34 13 355
Hongxi Ma China 8 145 1.0× 164 1.2× 119 1.1× 48 0.8× 27 0.8× 14 371
Chong Lu China 11 61 0.4× 190 1.4× 75 0.7× 106 1.8× 38 1.1× 45 382
Jingjing Duan China 10 82 0.6× 171 1.2× 58 0.6× 67 1.1× 68 2.0× 23 349
Xin Fan China 12 85 0.6× 183 1.3× 91 0.9× 80 1.3× 56 1.6× 31 395
Mélanie Bousquenaud France 9 48 0.3× 175 1.3× 70 0.7× 82 1.4× 25 0.7× 15 357
Dejun Cui China 10 53 0.4× 159 1.1× 55 0.5× 88 1.5× 45 1.3× 35 369
Jinghui Zheng China 9 66 0.5× 230 1.6× 95 0.9× 130 2.2× 95 2.8× 39 449
Chenfan Duan China 7 111 0.8× 190 1.4× 70 0.7× 96 1.6× 43 1.3× 7 374
Weiyuan Ma China 14 106 0.7× 221 1.6× 85 0.8× 109 1.8× 11 0.3× 24 408

Countries citing papers authored by Wenyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Wenyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Jiang more than expected).

Fields of papers citing papers by Wenyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Jiang. The network helps show where Wenyi Jiang may publish in the future.

Co-authorship network of co-authors of Wenyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Jiang. A scholar is included among the top collaborators of Wenyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Jiang. Wenyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wang, Dongxue, Wenting Huang, Junfeng Shi, et al.. (2025). FGF21, a modulator of astrocyte reactivity, protects against ischemic brain injury through anti-inflammatory and neurotrophic pathways. Acta Pharmacologica Sinica. 46(7). 1834–1851. 3 indexed citations
3.
Jiang, Wenyi, et al.. (2024). Mitochondrial KATP channel-mediated autophagy contributes to angiotensin II-induced vascular dysfunction in mice. Nutrition Metabolism and Cardiovascular Diseases. 34(6). 1571–1580. 3 indexed citations
4.
Wang, Dongxue, Yutao Wang, Junfeng Shi, et al.. (2024). Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration. International Immunopharmacology. 130. 111700–111700. 20 indexed citations
6.
Shen, Chunyi, Zhen Zhang, Yonggui Tian, et al.. (2021). Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway. BMC Medicine. 19(1). 283–283. 26 indexed citations
7.
Jiang, Wenyi, Jingyao Lian, Ying Yue, & Yi Zhang. (2021). IL‐33/ST2 as a potential target for tumor immunotherapy. European Journal of Immunology. 51(8). 1943–1955. 43 indexed citations
8.
Li, Yang, Ying Dong, Yanjun Li, et al.. (2019). IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer. International Journal of Cancer. 145(4). 1099–1110. 142 indexed citations
9.
Jiang, Wenyi, Geom Seog Seo, Youn‐Chul Kim, Dong Hwan Sohn, & Sung Hee Lee. (2015). PF2405, standardized fraction of Scutellaria baicalensis, ameliorates colitis in vitro and in vivo. Archives of Pharmacal Research. 38(6). 1127–1137. 20 indexed citations
10.
Seo, Geom Seog, Wenyi Jiang, Hua Jin, et al.. (2015). Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity. Oncotarget. 6(23). 19792–19806. 25 indexed citations
11.
Jiang, Wenyi, et al.. (2013). PF2401-SF, standardized fraction of Salvia miltiorrhiza shows anti-inflammatory activity in macrophages and acute arthritis in vivo. International Immunopharmacology. 16(2). 160–164. 33 indexed citations
12.
Park, Eun‐Jeon, et al.. (2013). PF2401-SF, Standardized Fraction of Salvia miltiorrhiza, Induces Apoptosis of Activated Hepatic Stellate Cells in Vitro and in Vivo. Molecules. 18(2). 2122–2134. 16 indexed citations
13.
Jiang, Wenyi, et al.. (2012). Apoptotic effect of propyl gallate in activated rat hepatic stellate cells. Archives of Pharmacal Research. 35(12). 2205–2210. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026